Key data on a new class of cardiovascular drugs expected soon

STAT News reports that key data on a new class of drugs for cardiovascular medicine are expected to emerge soon. Several major pharmaceutical companies are betting on an approach that involves targeting the lipoprotein(a) particle. The upcoming results are expected to show how well this approach works.

Targeting lipoprotein(a)

STAT News noted that several major pharmaceutical companies view work on lipoprotein(a) as a potential next major step in cardiovascular medicine. At the same time, the outlet does not provide specific study results or drug names in the available preview.

More current news is available on the UA.News Telegram channel Telegram.

Biotechnology roundup

The publication appeared in The Readout, a daily biotechnology roundup. The preview of the article also mentions GSK’s shingles vaccine, new financial investments in women’s health, and other biotechnology industry news.

The article’s author is STAT News national biotechnology reporter Elaine Chen. The publication was released on August 26, 2026.